Search Results: Repatha
Redirect to:
- From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN), the generic name or the nonproprietary name.
Evolocumab
Kamis, 2026-07-30 23:36:45Evolocumab, sold under the brand name Repatha, is a monoclonal antibody drug. It is an immunotherapy medication for the treatment of hyperlipidemia. Evolocumab...
Click to read more »Amgen
Senin, 2026-05-25 01:31:14osteoporosis and bone diseases ($6.6 billion in total 2025 revenues), Repatha (evolocumab) to treat hyperlipidemia ($3.0 billion in 2025 revenues), Otezla...
Click to read more »TrumpRx
Jumat, 2026-07-17 19:29:43including Gonal-f, on TrumpRx. AmgenNow, a website from Amgen that offers Repatha, is additionally set to appear on TrumpRx. At its launch on February 5...
Click to read more »Regeneron Pharmaceuticals
Sabtu, 2026-07-25 22:38:28practices to exclude Praluent from the market and elevate Amgen's rival Repatha. On February 4, 2020, the U.S. Department of Health and Human Services...
Click to read more »List of therapeutic monoclonal antibodies
Minggu, 2026-08-02 06:32:14Evinacumab Evkeeza mab human angiopoietin 3 Y dyslipidemia Evolocumab Repatha mab human PCSK9 Y hypercholesterolemia Exbivirumab mab human hepatitis...
Click to read more »PCSK9
Minggu, 2026-08-02 02:47:22S. Food and Drug Administration (FDA) on 24 July 2015, and evolocumab (Repatha, Amgen), approved on 27 August 2015; both were also authorised in the European...
Click to read more »List of drugs: Re
Rabu, 2026-07-15 19:32:27abciximab. repagermanium (INN) repaglinide (INN) Repan reparixin (USAN) Repatha repifermin (INN) repirinast (INN) repotrectinib (INN) repromicin (INN)...
Click to read more »Monoclonal antibody therapy
Minggu, 2026-08-02 04:43:38receptor Migraine headache prevention 761077 Link[dead link] evolocumab Repatha Amgen 8/27/2015 subcutaneous fully human PCSK9 Heterozygous familial hypercholesterolemia...
Click to read more »2017 in science
Jumat, 2026-07-31 05:25:45March 2017. Retrieved 17 March 2017. "Landmark Outcomes Study Shows That Repatha (Evolocumab) Decreases LDL-C To Unprecedented Low Levels And Reduces Risk...
Click to read more »